Ładuje się......
Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells
Glibenclamide is an oral hypoglycemic drug commonly prescribed for the treatment of type 2 diabetes mellitus, whose anti-tumor activity has been recently described in several human cancer cells. The mutagenic potential of such an antidiabetic drug and its recombinogenic activity in eukaryotic cells...
Zapisane w:
| Wydane w: | PLoS One |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Public Library of Science
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4372363/ https://ncbi.nlm.nih.gov/pubmed/25803314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120675 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|